Copyright ©2013 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2013; 5(11): 603-611
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.603
Table 1 Risk stratification and need for cytomegalovirus prophylaxis
Donor CMV IgG statusRecipient CMV IgG statusRisk type1Need for CMV prophylaxis
PositivePositiveLow riskLow
PositiveNegativeHigh riskHigh
NegativePositiveLow riskLow
NegativeNegativeLow riskLow
Table 2 Risk of de novo hepatitis B in recipients receiving grafts from hepatitis B core antibody positive donors
Recipient statusRecipient HBVantibody status Risk of de novo hepatitis
No prophylaxisWith prophylaxis
HBV naiveHBcAb-, HBsAb-58%11%
No past infection, immunizedHBcAb-, HBsAb+18%2%
Past infection, immuneHBcAb+, HBsAb+4%3%
Past infection, not immuneHBcAb-, HBsAb+14%3%